These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35659482)

  • 21. [High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series].
    Brito M; Sanchez P; Velho S; Miranda N; Leal da Costa F; Ferreira I; Teixeira G; Guimarães A; Abecasis M; Passos Coelho JL
    Acta Med Port; 2011; 24(4):533-44. PubMed ID: 22521011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of residual disease after chemotherapy in germ cell tumors.
    King J; Adra N; Einhorn LH
    Curr Opin Oncol; 2020 May; 32(3):250-255. PubMed ID: 32168037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of testicular cancer].
    Droz JP; Boyle H; Culine S; Fizazi K; Fléchon A; Massard C
    Bull Cancer; 2013 Dec; 100(12):1319-32. PubMed ID: 24316884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond stage I germ cell tumors: current status regarding treatment and long-term toxicities.
    Haugnes HS; Stephenson AJ; Feldman DR
    Am Soc Clin Oncol Educ Book; 2014; ():e180-90. PubMed ID: 24857101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of germ cell tumors in children: approaches to cure.
    Göbel U; Calaminus G; Schneider DT; Schmidt P; Haas RJ;
    Onkologie; 2002 Feb; 25(1):14-22. PubMed ID: 11893878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
    Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
    Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206.
    Adra N; Einhorn LH; Althouse SK; Ammakkanavar NR; Musapatika D; Albany C; Vaughn D; Hanna NH
    Ann Oncol; 2018 Jan; 29(1):209-214. PubMed ID: 29045540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specialist management of testicular cancer: Report of the last 10 years at a Portuguese tertiary referral academic centre.
    Marques-Pinto A; Gomes AI; Febra J; Rosendo E; Castanheira de Oliveira M; Fraga A; La Fuente de Carvalho J; Louro N
    Arch Ital Urol Androl; 2021 Jun; 93(2):153-157. PubMed ID: 34286547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thoracic Metastasectomy in Germ Cell Tumor Patients Treated With First-line Versus Salvage Therapy.
    Caso R; Jones GD; Tan KS; Bosl GJ; Funt SA; Sheinfeld J; Reuter VE; Amar D; Fischer G; Molena D; Rocco G; Bains MS; Feldman DR; Jones DR
    Ann Thorac Surg; 2021 Apr; 111(4):1141-1149. PubMed ID: 32882201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.
    Pruitt R; DaSilva NS; Cappellano A; Belessiotis C; Diez B; Gardner S; Allen J; Weinblatt M; Gottardo N; Dhall G; Finlay JL
    Pediatr Blood Cancer; 2015 Nov; 62(11):1920-4. PubMed ID: 26054044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
    Balzer BL; Ulbright TM
    Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical management of complex residual masses following systemic chemotherapy for metastatic testicular germ cell tumours.
    Heidenreich A; Haidl F; Paffenholz P; Pape C; Neumann U; Pfister D
    Ann Oncol; 2017 Feb; 28(2):362-367. PubMed ID: 27831507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) Experience.
    Miller MI; Feifer A; Feldman DR; Carver BS; Bosl GJ; Motzer RJ; Bajorin DF; Sheinfeld J
    Urology; 2019 Feb; 124():174-178. PubMed ID: 30296502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of residual non-retroperitoneal disease following chemotherapy for germ cell tumor.
    Sadeghi N; Badalato GM; Kates M; McKiernan JM
    Urol Oncol; 2011; 29(6):837-41. PubMed ID: 21489835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.
    Stephenson AJ; Aprikian AG; Gilligan TD; Oldenburg J; Powles T; Toner GC; Waters WB
    Urology; 2011 Oct; 78(4 Suppl):S444-55. PubMed ID: 21986224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor.
    Nason GJ; Jewett MAS; Bostrom PJ; Goldberg H; Hansen AR; Bedard PL; Sturgeon J; Warde P; Chung P; Anson-Cartwright L; Sweet J; Atenafu EG; O'Malley M; Hamilton RJ
    Eur Urol Oncol; 2021 Apr; 4(2):289-296. PubMed ID: 32907779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Body Mass Index and Outcomes in Germ-Cell Tumors.
    McGregor BA; Miller RE; O'Donnell E; Albiges LK; Sweeney CJ; Markt SC
    Clin Genitourin Cancer; 2019 Aug; 17(4):283-290. PubMed ID: 31129146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histologic and Oncologic Outcomes Following Liver Mass Resection With Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Germ Cell Tumor.
    Pietzak EJ; Assel M; Becerra MF; Tennenbaum D; Feldman DR; Bajorin DF; Motzer RJ; Bosl GJ; Carver BS; Sjoberg DD; Sheinfeld J
    Urology; 2018 Aug; 118():114-118. PubMed ID: 29704586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late relapsing germ cell tumors with elevated tumor markers.
    Che Y; Lusch A; Winter C; Große Siemer R; Buddensieck C; Albers P; Hiester A
    World J Urol; 2022 Feb; 40(2):363-371. PubMed ID: 34518930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group.
    Winter C; Pfister D; Busch J; Bingöl C; Ranft U; Schrader M; Dieckmann KP; Heidenreich A; Albers P
    Eur Urol; 2012 Feb; 61(2):403-9. PubMed ID: 22078334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.